Index -
P/E 10.81
EPS (ttm) 0.45
Insider Own 28.05%
Shs Outstand 47.65M
Perf Week -2.20%
Market Cap 235.26M
Forward P/E 28.71
EPS next Y 0.17
Insider Trans -0.82%
Shs Float 34.68M
Perf Month -12.86%
Income 21.59M
PEG -
EPS next Q -0.22
Inst Own 54.89%
Short Float 9.59%
Perf Quarter -1.41%
Sales 235.64M
P/S 1.00
EPS this Y -42.22%
Inst Trans -2.11%
Short Ratio 5.75
Perf Half Y 117.86%
Book/sh 1.12
P/B 4.35
EPS next Y -34.62%
ROA 9.54%
Short Interest 3.33M
Perf Year 79.41%
Cash/sh 1.99
P/C 2.45
EPS next 5Y -
ROE 57.54%
52W Range 2.13 - 7.73
Perf YTD 12.70%
Dividend Est. -
P/FCF 8.76
EPS past 5Y -
ROI 17.12%
52W High -36.87%
Beta 1.31
Dividend TTM -
Quick Ratio 1.50
Sales past 5Y -0.59%
Gross Margin 73.40%
52W Low 129.11%
ATR (14) 0.34
Dividend Ex-Date -
Current Ratio 1.57
EPS Y/Y TTM 15796.55%
Oper. Margin 14.12%
RSI (14) 40.72
Volatility 5.73% 5.86%
Employees 185
Debt/Eq 2.09
Sales Y/Y TTM 3.34%
Profit Margin 9.16%
Recom 3.00
Target Price 4.33
Option/Short Yes / Yes
LT Debt/Eq 1.36
EPS Q/Q 308.66%
Payout 0.00%
Rel Volume 0.40
Prev Close 4.83
Sales Surprise -1.84%
EPS Surprise -13.33%
Sales Q/Q 9.90%
Earnings May 02 AMC
Avg Volume 578.88K
Price 4.88
SMA20 -8.32%
SMA50 -13.06%
SMA200 17.36%
Trades
Volume 231,234
Change 1.04%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-28-21 Upgrade
Citigroup
Neutral → Buy
$11
Jun-25-20 Resumed
BofA/Merrill
Underperform
$9
Oct-08-19 Downgrade
Goldman
Neutral → Sell
$24 → $8
May-10-19 Downgrade
Citigroup
Buy → Neutral
$24
May-10-19 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$57 → $20
Jan-17-19 Initiated
Leerink Partners
Mkt Perform
$21
Jan-03-19 Downgrade
Guggenheim
Buy → Neutral
Nov-19-18 Upgrade
Goldman
Sell → Neutral
Nov-02-18 Downgrade
JP Morgan
Neutral → Underweight
Nov-02-18 Downgrade
BofA/Merrill
Buy → Underperform
Oct-01-18 Initiated
Cantor Fitzgerald
Overweight
$75
Sep-17-18 Initiated
Goldman
Sell
$42
May-11-18 Reiterated
Stifel
Buy
$95 → $87
Nov-10-17 Reiterated
RBC Capital Mkts
Sector Perform
$92 → $108
Nov-10-17 Reiterated
Citigroup
Buy
$156 → $164
Oct-02-17 Reiterated
Stifel
Buy
$110 → $130
Sep-11-17 Reiterated
Credit Suisse
Outperform
$118 → $136
Jul-10-17 Resumed
Leerink Partners
Outperform
$115
Jun-06-17 Reiterated
RBC Capital Mkts
Sector Perform
$60 → $88
May-25-17 Reiterated
RBC Capital Mkts
Sector Perform
$40 → $60
Show Previous Ratings
Apr-25-24 10:02AM
Apr-18-24 04:15PM
Apr-11-24 06:00PM
Apr-03-24 05:30PM
Mar-22-24 09:25AM
08:30AM
Loading…
Mar-20-24 08:30AM
Mar-02-24 08:29AM
Mar-01-24 09:55AM
(Thomson Reuters StreetEvents) -5.31%
09:40AM
09:39AM
Feb-29-24 04:41PM
04:40PM
(Associated Press Finance)
04:05PM
Feb-27-24 06:30PM
11:51AM
04:10PM
Loading…
Feb-22-24 04:10PM
Feb-15-24 04:10PM
Feb-13-24 08:30AM
Jan-31-24 12:58PM
Jan-11-24 04:07PM
Jan-06-24 11:02AM
Dec-11-23 08:30AM
Nov-20-23 11:47AM
Nov-06-23 05:15PM
Nov-03-23 12:16PM
09:34AM
(Thomson Reuters StreetEvents)
09:31AM
Nov-02-23 07:42PM
04:47PM
(Associated Press Finance)
04:05PM
04:14PM
Loading…
Oct-19-23 04:14PM
Oct-14-23 12:30PM
Oct-04-23 05:30PM
Sep-22-23 07:57AM
Sep-21-23 04:10PM
Aug-31-23 04:07PM
Aug-08-23 08:30AM
Aug-04-23 12:36PM
09:23AM
(Thomson Reuters StreetEvents)
Aug-03-23 05:17PM
04:05PM
Jul-20-23 04:15PM
Jun-13-23 09:30AM
Jun-06-23 05:03PM
Jun-04-23 09:00AM
May-28-23 10:06AM
May-22-23 11:07AM
May-05-23 05:15PM
12:45PM
09:44AM
(Thomson Reuters StreetEvents)
May-04-23 05:32PM
04:04PM
Apr-20-23 04:15PM
Apr-17-23 06:49AM
Apr-11-23 05:15PM
Mar-14-23 08:30AM
Mar-06-23 09:48AM
Mar-03-23 05:15PM
02:20PM
06:22AM
(Thomson Reuters StreetEvents)
Mar-02-23 04:05PM
Feb-28-23 04:15PM
Feb-19-23 02:05PM
Feb-16-23 04:31PM
Feb-07-23 05:30PM
Feb-01-23 08:30AM
Jan-25-23 06:19AM
Jan-12-23 04:15PM
Jan-11-23 05:30PM
Jan-09-23 08:55AM
Dec-20-22 08:31AM
Dec-15-22 03:39PM
Dec-07-22 06:03PM
Dec-05-22 05:30PM
Dec-01-22 08:36AM
Nov-28-22 09:55AM
Nov-22-22 09:15AM
08:50AM
Nov-21-22 05:25PM
Nov-17-22 09:40AM
Nov-14-22 10:10AM
09:50AM
Nov-11-22 10:20AM
Nov-09-22 10:43AM
06:02AM
Nov-07-22 01:02PM
(Simply Wall St.) +15.50%
Nov-04-22 12:29PM
12:20PM
12:18PM
11:18AM
Nov-03-22 06:45PM
04:05PM
Nov-02-22 05:30PM
Oct-27-22 04:05AM
Oct-20-22 04:15PM
Oct-12-22 09:31AM
Oct-04-22 05:30PM
Sep-21-22 11:35AM
10:15AM
Sep-20-22 04:05PM
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
AUERBACH ALAN H President and CEO Jan 03 '24 Sale 4.49 41,396 185,698 6,936,947 Jan 05 06:56 PM NOUGUES MAXIMO F Chief Financial Officer Jan 03 '24 Sale 4.49 15,682 70,348 128,666 Jan 05 06:49 PM Ludwig Jeffrey Jerome Chief Commercial Officer Jan 03 '24 Sale 4.49 12,956 58,119 99,970 Jan 05 07:00 PM HUNT DOUGLAS M See Remarks Jan 03 '24 Sale 4.49 8,358 37,493 103,319 Jan 05 06:42 PM Wong Alvin F Chief Scientific Officer Jan 03 '24 Sale 4.49 7,733 34,689 98,214 Jan 05 07:03 PM Wong Alvin F Chief Scientific Officer Dec 04 '23 Sale 3.76 280 1,053 97,934 Jan 10 04:41 PM MILLER MICHAEL PATRICK Director Nov 07 '23 Sale 2.83 25,000 70,802 43,358 Nov 09 04:19 PM AUERBACH ALAN H President and CEO Jul 03 '23 Sale 3.31 60,698 200,983 6,978,343 Jul 06 07:03 PM NOUGUES MAXIMO F Chief Financial Officer Jul 03 '23 Sale 3.31 14,680 48,608 144,348 Jul 06 07:12 PM Ludwig Jeffrey Jerome Chief Commercial Officer Jul 03 '23 Sale 3.31 12,103 40,075 112,926 Jul 06 07:08 PM HUNT DOUGLAS M See Remarks Jul 03 '23 Sale 3.31 7,809 25,857 111,677 Jul 06 07:06 PM Wong Alvin F Chief Scientific Officer Jul 03 '23 Sale 3.31 6,938 22,973 105,947 Jul 06 07:16 PM Senderowicz Adrian Director Jun 13 '23 Sale 3.45 27,000 93,280 0 Jun 15 09:03 PM WILSON TROY EDWARD Director Jun 13 '23 Sale 3.45 27,000 93,269 350 Jun 15 09:14 PM MOYES JAY M Director Jun 13 '23 Sale 3.45 22,000 75,970 16,322 Jun 15 09:10 PM MILLER MICHAEL PATRICK Director Jun 13 '23 Sale 3.45 13,500 46,630 41,358 Jun 15 08:28 PM Dorval Allison Director Jun 13 '23 Sale 3.45 10,000 34,500 17,000 Jun 15 09:01 PM Stuglik Brian M Director Jun 13 '23 Sale 3.46 9,900 34,252 31,958 Jun 15 09:06 PM Wong Alvin F Chief Scientific Officer Jun 02 '23 Sale 3.45 269 928 112,885 Jun 06 04:36 PM
Index -
P/E 9.73
EPS (ttm) 2.11
Insider Own 0.01%
Shs Outstand 382.86M
Perf Week 2.09%
Market Cap 7.70B
Forward P/E 9.88
EPS next Y 2.07
Insider Trans 0.00%
Shs Float 375.56M
Perf Month -7.66%
Income 824.66M
PEG 1.13
EPS next Q 0.58
Inst Own 5.94%
Short Float 0.20%
Perf Quarter -0.39%
Sales 13.48B
P/S 0.57
EPS this Y 4.43%
Inst Trans -10.00%
Short Ratio 2.74
Perf Half Y -0.87%
Book/sh 22.29
P/B 0.92
EPS next Y 5.80%
ROA 3.43%
Short Interest 0.76M
Perf Year 4.01%
Cash/sh 3.62
P/C 5.67
EPS next 5Y 8.60%
ROE 9.61%
52W Range 18.52 - 22.71
Perf YTD -4.21%
Dividend Est. 1.32 (6.45% )
P/FCF 5.20
EPS past 5Y -2.67%
ROI 5.30%
52W High -9.73%
Beta 0.84
Dividend TTM 0.70 (3.40%)
Quick Ratio 0.92
Sales past 5Y -2.34%
Gross Margin 21.22%
52W Low 10.69%
ATR (14) 0.27
Dividend Ex-Date Sep 28, 2023
Current Ratio 0.94
EPS Y/Y TTM 18.79%
Oper. Margin 9.94%
RSI (14) 41.07
Volatility 0.91% 1.16%
Employees 5579
Debt/Eq 1.01
Sales Y/Y TTM 0.42%
Profit Margin 6.12%
Recom 1.43
Target Price 24.48
Option/Short Yes / Yes
LT Debt/Eq 0.82
EPS Q/Q -14.02%
Payout -
Rel Volume 0.82
Prev Close 20.49
Sales Surprise 0.56%
EPS Surprise 10.26%
Sales Q/Q 5.95%
Earnings Feb 05 BMO
Avg Volume 275.70K
Price 20.50
SMA20 -1.11%
SMA50 -4.59%
SMA200 -1.85%
Trades
Volume 226,254
Change 0.05%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-31-19 Upgrade
JP Morgan
Neutral → Overweight
May-21-19 Initiated
Macquarie
Outperform
Dec-07-18 Upgrade
Nomura
Neutral → Buy
Oct-30-18 Downgrade
CLSA
Buy → Outperform
Oct-26-18 Upgrade
HSBC Securities
Hold → Buy
Feb-23-18 Downgrade
Macquarie
Outperform → Neutral
Jan-11-18 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Dec-01-17 Upgrade
Citigroup
Neutral → Buy
Apr-24-17 Downgrade
Citigroup
Buy → Neutral
Oct-25-16 Downgrade
Macquarie
Outperform → Neutral
Oct-24-16 Upgrade
CLSA
Outperform → Buy
Apr-27-16 Downgrade
HSBC Securities
Buy → Hold
Nov-02-15 Downgrade
JP Morgan
Overweight → Neutral
Jan-22-13 Upgrade
HSBC Securities
Neutral → Overweight
Sep-27-11 Downgrade
HSBC Securities
Overweight → Neutral
Feb-23-09 Upgrade
JP Morgan
Neutral → Overweight
Jan-14-09 Upgrade
Citigroup
Hold → Buy
Jul-29-08 Upgrade
Credit Suisse
Neutral → Outperform
Dec-05-07 Downgrade
Bear Stearns
Outperform → Peer Perform
Jul-10-07 Upgrade
Citigroup
Hold → Buy
Show Previous Ratings
Today 07:47AM
Apr-18-24 10:18PM
08:16AM
Apr-11-24 08:00AM
Mar-31-24 10:07PM
04:09AM
Loading…
Feb-28-24 04:09AM
Feb-27-24 07:17PM
Feb-26-24 08:30AM
08:00AM
07:09AM
Feb-08-24 08:42PM
Nov-22-23 07:54PM
(The Wall Street Journal)
Nov-16-23 04:35AM
Nov-13-23 10:42AM
Nov-09-23 11:23AM
12:27AM
Loading…
Nov-08-23 12:27AM
Nov-07-23 08:50AM
Oct-30-23 07:52AM
Oct-22-23 01:00AM
Oct-18-23 05:32AM
Oct-17-23 11:00AM
08:57AM
Oct-13-23 01:51AM
(The Wall Street Journal)
Oct-02-23 09:03AM
Sep-25-23 09:00PM
Sep-19-23 08:50AM
Sep-18-23 08:48PM
Sep-17-23 10:37PM
Aug-23-23 05:18PM
Aug-18-23 09:45AM
10:51PM
Loading…
Aug-13-23 10:51PM
10:43PM
Aug-09-23 12:11PM
Aug-08-23 05:07AM
Jul-27-23 02:11PM
05:00AM
Jun-29-23 08:07PM
09:11AM
06:00AM
Jun-26-23 10:00AM
Jun-08-23 09:00PM
10:00AM
May-18-23 06:15AM
May-10-23 09:53AM
Apr-27-23 07:40AM
Mar-15-23 07:46AM
Mar-07-23 05:00AM
Mar-06-23 09:40AM
09:24AM
Feb-27-23 04:00AM
Feb-26-23 07:33PM
Feb-18-23 06:00PM
Feb-16-23 09:40AM
Feb-09-23 12:09AM
Jan-31-23 09:40AM
Jan-25-23 07:07AM
Jan-24-23 09:40AM
Jan-23-23 07:09AM
07:07AM
Oct-27-22 12:00PM
Aug-10-22 01:14PM
Aug-07-22 12:45PM
Mar-10-22 05:30AM
(The Wall Street Journal)
Feb-14-22 06:28PM
(American City Business Journals)
Feb-08-22 10:38AM
Feb-06-22 06:00PM
Feb-02-22 05:38PM
01:38PM
09:38AM
Jan-19-22 09:38PM
Jan-08-22 07:00PM
Jan-06-22 08:11PM
Jan-01-22 07:00PM
Dec-12-21 04:00PM
Sep-07-21 09:15PM
09:00PM
Jul-01-21 12:00PM
Jun-16-21 11:48PM
12:00PM
Jun-12-21 01:00PM
May-25-21 12:00PM
May-11-21 05:30PM
May-07-21 08:51AM
Apr-21-21 06:39AM
Apr-11-21 06:20AM
Apr-01-21 07:42AM
Mar-16-21 04:43AM
04:35AM
Jan-22-21 11:05AM
Jan-06-21 08:04PM
Jan-05-21 10:35PM
Dec-09-20 10:25AM
Nov-29-20 09:46AM
Oct-21-20 03:49AM
Oct-15-20 09:55PM
06:51PM
Oct-07-20 05:39PM
Sep-22-20 04:17PM
Sep-07-20 06:28AM
Aug-23-20 11:02PM
SK Telecom Co., Ltd. engages in the provision of wireless telecommunication and internet services. Its products include mobile phones, wireless data, information communication, and others. The company was founded on March 29, 1984 and is headquartered in Seoul, South Korea.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite